COVID-19 and Subsequent Life-threatening Secondary Infections

Pavankumar Kamat

Disclosures

November 28, 2021

Takeaway      

  • Patients with COVID-19 may have an increased risk of subsequent life-threatening secondary infections (sepsis, endocarditis and central nervous system infections), to an equal extent or even beyond risk elevations seen with seasonal influenza.

  • The risk continues to remain high in hospitalized patients with severe COVID-19 and seasonal influenza after being discharged from the hospital.

Why this matters

  • Findings highlight the significance of continued surveillance of patients with both current and prior severe COVID-19.

Study design

  • This matched cohort study included 5151 participants diagnosed with or hospitalised with COVID-19 and 51,402 matched control participants, identified using data from the UK Biobank (2006-2010).

  • An additional matched cohort was constructed of individuals diagnosed with seasonal influenza (6169 exposed and 61,555 unexposed individuals).

  • The association between COVID-19 and life-threatening secondary infections with high mortality rates was assessed.

  • Funding: 1.3.5 Project for Disciplines of Excellence and others.

Key results

  • During a median follow-up of 12.71 weeks, the incidence rate of life-threatening secondary infections was 2.23 (123/55.15) and 0.25 (151/600.55) per 1000 person-weeks for patients with COVID-19 and matched control participants, respectively, with a corresponding adjusted HR [aHR] of 8.19 (95% CI, 6.33-10.59).

  • The corresponding aHR of life-threatening secondary infections was in patients with seasonal influenza was 4.50 (95% CI, 3.34-6.08; Pdifference<.01).

  • The risk of life-threatening secondary infections also remained high after discharge in hospitalized patients with severe COVID-19 (aHR, 6.28; 95% CI, 4.05-9.75) and seasonal influenza (aHR, 6.01; 95% CI, 3.53-10.26; Pdifference=.902).

Limitations

  • Cases with life-threatening secondary infections were limited.

  • Study population was predominantly White (94.6%).

Hou C, Hu Y, Yang H, Chen W, Zeng Y, Ying Z, Hu Y, Sun Y, Qu Y, Gottfreðsson M, Valdimarsdóttir UA, Song H. COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank. BMC Med. 2021;19(1):301. doi: 10.1186/s12916-021-02177-0. PMID: 34781951 View Full Text.

 

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....